Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.2 |